Westcot Ventures Corp. Announces Name Change to “WPD Pharmaceuticals Inc.”
January 14, 2020 05:00 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Westcot Ventures Corp (CSE: WBIO) (the “Company”), a clinical stage pharmaceutical company, announces that it has changed its name from...
WPD Pharmaceuticals’ New Discovery for Cancer Targeting Drugs is Granted Patent
January 09, 2020 07:25 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE: WBIO) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to announce that on...
WPD Pharmaceuticals Provides 2019 Corporate Year End Review
January 08, 2020 03:05 ET
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Westcot Ventures Corp. (CSE: WBIO) (the “Company”), and its wholly-owned subsidiary WPD Pharmaceuticals sp. z.o.o (“WPD”), a clinical...
Westcot Ventures Corp. Announces Closing of Transaction of WPD Pharmaceuticals Sp. Z.o.o.
December 24, 2019 01:14 ET
|
Westcot Ventures Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Westcot Ventures Corp. (the “Company” or...